Pub Date : 2022-01-01DOI: 10.29262/ram.v69iSupl1.1033
Daniela Rivero-Yeverino, Aída Inés López-García, Chrystopherson Gengyny Caballero-López, Juan Jesús Ríos-López, José Sergio Papaqui-Tapia, Elisa Elisa Ortega-Jordá Rodríguez, Armando Álvarez-Rivera, Dulce Mariel Ruiz-Sánchez, Edgar Flores-Gonzaga
An increasing number of studies are analyzing the relationship between serum vitamin D levels and the development of sensitization and allergic diseases in genetically predisposed individuals, as well as the impact of vitamin D supplementation. This article reviews the literature on this subject. Clinical trials, meta-analyses and systematic reviews consulted in PubMed, EMBASE, Scopus, Ovid, Wiley Online Library, Springer, Cochrane and manual resources were included, with the keywords: vitamin D, 25 hydroxyvitamin D, cholecalciferol, asthma, rhinitis, allergy, 25-OH-D, 1,25 hydroxyvitamin D, supplementation. The results show a positive linear trend, however, differ. We should keep in mind that in the studies there is heterogeneity of population groups and associated factors, which may modify such studies. It is necessary to increase research to clarify this relationship and to have successful interventions from the patient's approach to the strengthening of pharmacological and immunological treatment of allergic patients with these diseases.
{"title":"[Vitamin D and respiratory allergy: state of the art].","authors":"Daniela Rivero-Yeverino, Aída Inés López-García, Chrystopherson Gengyny Caballero-López, Juan Jesús Ríos-López, José Sergio Papaqui-Tapia, Elisa Elisa Ortega-Jordá Rodríguez, Armando Álvarez-Rivera, Dulce Mariel Ruiz-Sánchez, Edgar Flores-Gonzaga","doi":"10.29262/ram.v69iSupl1.1033","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.1033","url":null,"abstract":"<p><p>An increasing number of studies are analyzing the relationship between serum vitamin D levels and the development of sensitization and allergic diseases in genetically predisposed individuals, as well as the impact of vitamin D supplementation. This article reviews the literature on this subject. Clinical trials, meta-analyses and systematic reviews consulted in PubMed, EMBASE, Scopus, Ovid, Wiley Online Library, Springer, Cochrane and manual resources were included, with the keywords: vitamin D, 25 hydroxyvitamin D, cholecalciferol, asthma, rhinitis, allergy, 25-OH-D, 1,25 hydroxyvitamin D, supplementation. The results show a positive linear trend, however, differ. We should keep in mind that in the studies there is heterogeneity of population groups and associated factors, which may modify such studies. It is necessary to increase research to clarify this relationship and to have successful interventions from the patient's approach to the strengthening of pharmacological and immunological treatment of allergic patients with these diseases.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s46-s54"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39657051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Latex allergy is a major problem worldwide due to both the severity of the symptomatology it produces and the risk groups that are exposed to it. Complete avoidance is difficult, if not impossible, due to its ubiquity. Natural rubber latex (NRL) is a natural polymer that is released by the Hevea brasiliensis (Hev b) tree, which functions as a protective sealant. It is currently used for the manufacture of health-care products such as tube caps, pistons, masks, and cannulas. The purpose of this review is to highlight the epidemiological, clinical, and diagnostic aspects of NRL allergy, and to conduct a review of the literature on its management through a bibliographic search of articles in databases such as PubMed, Cochrane, UpToDate, and Google Scholar, up to September 2021. About 121 articles were reviewed, of which 76 were used as a reference. We concluded that latex allergy is an entity for which its treatment, even nowadays, is avoidance, despite having a worldwide prevalence of 4.3 % and representing a surgical complication in about 20 % of surgeries with an anaphylactic reaction and a mortality rate that can reach 9 %. The only treatment that could modify the evolution of this disease is immunotherapy, but there are no standardized extracts yet and it has not been possible to determine the safest and most effective way to apply it.
乳胶过敏是世界范围内的一个主要问题,因为它产生的症状的严重性和暴露于它的风险群体。由于其无处不在,完全避免是困难的,如果不是不可能的话。天然胶乳(NRL)是一种天然聚合物,由巴西橡胶树(Hevea brasiliensis, Hev b)树释放,具有保护密封的功能。它目前用于制造医疗保健产品,如管帽、活塞、口罩和套管。本综述的目的是强调NRL过敏的流行病学、临床和诊断方面,并通过对PubMed、Cochrane、UpToDate和Google Scholar等数据库中截至2021年9月的文章进行书目检索,对其管理方面的文献进行综述。共评审121篇文章,其中76篇作为参考文献。我们的结论是乳胶过敏是一个实体,即使在今天,它的治疗是避免的,尽管在世界范围内有4.3%的患病率,并且在大约20%的手术中出现了外科并发症,伴有过敏反应,死亡率可达到9%。唯一可以改变这种疾病演变的治疗方法是免疫疗法,但目前还没有标准化的提取物,也不可能确定最安全、最有效的应用方法。
{"title":"[Latex allergy: therapeutic options].","authors":"Claudia Elizabeth Jiménez-Carrillo, Karen Miroslava Piña-Ramos, Carolina Meza-Arrayales, Kathya Pamela Villaruel-Flores, Alejandro García-Aguirre","doi":"10.29262/ram.v69iSupl1.1035","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.1035","url":null,"abstract":"<p><p>Latex allergy is a major problem worldwide due to both the severity of the symptomatology it produces and the risk groups that are exposed to it. Complete avoidance is difficult, if not impossible, due to its ubiquity. Natural rubber latex (NRL) is a natural polymer that is released by the Hevea brasiliensis (Hev b) tree, which functions as a protective sealant. It is currently used for the manufacture of health-care products such as tube caps, pistons, masks, and cannulas. The purpose of this review is to highlight the epidemiological, clinical, and diagnostic aspects of NRL allergy, and to conduct a review of the literature on its management through a bibliographic search of articles in databases such as PubMed, Cochrane, UpToDate, and Google Scholar, up to September 2021. About 121 articles were reviewed, of which 76 were used as a reference. We concluded that latex allergy is an entity for which its treatment, even nowadays, is avoidance, despite having a worldwide prevalence of 4.3 % and representing a surgical complication in about 20 % of surgeries with an anaphylactic reaction and a mortality rate that can reach 9 %. The only treatment that could modify the evolution of this disease is immunotherapy, but there are no standardized extracts yet and it has not been possible to determine the safest and most effective way to apply it.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s55-s68"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39657052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This allergy is a hypersensitivity reaction that is triggered by contact with latex. Symptoms vary depending on factors such as route, frequency, and exposure dose, as well as individual susceptibility. The clinical manifestations can be localized at the site of contact with latex or generalized. Exposure can occur directly as a result of contact with the skin and mucous membranes, that is by touching or being touched by objects with latex, or by inhaling (breathing) particles from objects with latex. Contact can also be indirect; for example, by ingesting food that has been handled by a worker wearing latex gloves or by having contact with a person who has been blowing up balloons. The diagnosis of latex allergy is made based on the patient's medical history and on what has been reported in the interrogation, and it is complemented with in vivo studies (such as skin tests and provocation tests) or in vitro studies (determination of specific IgE). The fundamental pillar in the treatment of latex allergy is the education of the patient to achieve the avoidance of products made with this material or the contact and intake of food that has had contact with latex. In view of the foregoing, latex allergy has a great medical and social relevance due to all the safety measures that the patient must take.
{"title":"[Latex allergy: a review on the most important aspects].","authors":"Sandra Nora González-Díaz, Alejandra Macías-Weinmann, Maricela Hernández-Robles, Natalhie Acuña-Ortega Acuña-Ortega","doi":"10.29262/ram.v69iSupl1.1012","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.1012","url":null,"abstract":"<p><p>This allergy is a hypersensitivity reaction that is triggered by contact with latex. Symptoms vary depending on factors such as route, frequency, and exposure dose, as well as individual susceptibility. The clinical manifestations can be localized at the site of contact with latex or generalized. Exposure can occur directly as a result of contact with the skin and mucous membranes, that is by touching or being touched by objects with latex, or by inhaling (breathing) particles from objects with latex. Contact can also be indirect; for example, by ingesting food that has been handled by a worker wearing latex gloves or by having contact with a person who has been blowing up balloons. The diagnosis of latex allergy is made based on the patient's medical history and on what has been reported in the interrogation, and it is complemented with in vivo studies (such as skin tests and provocation tests) or in vitro studies (determination of specific IgE). The fundamental pillar in the treatment of latex allergy is the education of the patient to achieve the avoidance of products made with this material or the contact and intake of food that has had contact with latex. In view of the foregoing, latex allergy has a great medical and social relevance due to all the safety measures that the patient must take.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s31-s37"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39657049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.29262/ram.v69iSupl1.1009
José Jesús López-Tiro, Elvia Angélica Contreras-Contreras, Nancy Nayeli Cruz-Arellanes, Mario Alberto Camargo-Pirrón, Erick Oswaldo Cabrera-Buendía, Guadalupe Isadora Ramírez-Pérez, Guillermo Vega-Acevedo
The COVID-19 pandemic has collapsed the health systems of many countries in the world and comorbidities in adults have exponentially increased their mortality; in matters of asthma, it has not been possible to establish a defining relationship in mortality. The clinical manifestations of asthmatic patients with SARS COV 2 are presented in a wide range; from asymptomatic to those who experience acute respiratory failure. The most sensitive method for the diagnosis of SARS-CoV-2 infection is RT-PCR. Antigen and serologic tests are quicker than RT-PCR, but they are less sensitive. Radiologic studies and the computed tomography of the chest assist in the diagnosis and follow-up of SARS-CoV-2 infection. The use of spirometry for diagnosis and follow-up is restricted due to the elevated risk of contagion. It has been shown that eosinophilia and TH2 inflammation, due to their antiviral immune effect, are protective factors against severe SARS-CoV-2/COVID-19. Patients with mild asthma express less angiotensin converting enzyme receptors (ACE2), and those with neutrophilic asthma express it in greater proportion, which suggests more severe presentations of COVID-19. The conventional asthma treatment modulates the SARS-CoV-2/COVID-19 immune response, which is why patients with controlled asthma have non-severe manifestations of COVID 19, however, the mechanisms are not clear.
{"title":"[Asthma and COVID-19].","authors":"José Jesús López-Tiro, Elvia Angélica Contreras-Contreras, Nancy Nayeli Cruz-Arellanes, Mario Alberto Camargo-Pirrón, Erick Oswaldo Cabrera-Buendía, Guadalupe Isadora Ramírez-Pérez, Guillermo Vega-Acevedo","doi":"10.29262/ram.v69iSupl1.1009","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.1009","url":null,"abstract":"<p><p>The COVID-19 pandemic has collapsed the health systems of many countries in the world and comorbidities in adults have exponentially increased their mortality; in matters of asthma, it has not been possible to establish a defining relationship in mortality. The clinical manifestations of asthmatic patients with SARS COV 2 are presented in a wide range; from asymptomatic to those who experience acute respiratory failure. The most sensitive method for the diagnosis of SARS-CoV-2 infection is RT-PCR. Antigen and serologic tests are quicker than RT-PCR, but they are less sensitive. Radiologic studies and the computed tomography of the chest assist in the diagnosis and follow-up of SARS-CoV-2 infection. The use of spirometry for diagnosis and follow-up is restricted due to the elevated risk of contagion. It has been shown that eosinophilia and TH2 inflammation, due to their antiviral immune effect, are protective factors against severe SARS-CoV-2/COVID-19. Patients with mild asthma express less angiotensin converting enzyme receptors (ACE2), and those with neutrophilic asthma express it in greater proportion, which suggests more severe presentations of COVID-19. The conventional asthma treatment modulates the SARS-CoV-2/COVID-19 immune response, which is why patients with controlled asthma have non-severe manifestations of COVID 19, however, the mechanisms are not clear.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s15-s23"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39798202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.29262/ram.v69iSupl1.1010
Sandra Nora González-Díaz, Cindy Elizabeth de Lira-Quezada, Rosalaura Virginia Villarreal-González, José Ignacio Canseco-Villarreal
La contaminación del aire, el cambio climático y la reducción de la diversidad biológica son amenazas importantes para la salud humana. En las últimas décadas se ha observado un aumento en las enfermedades alérgicas incluyendo asma y rinoconjuntivitis. Hasta al 40% de la población mundial pueden presentar alguna enfermedad alérgica representando un impacto significativo en la calidad de vida de quienes la padecen, siendo la contaminación ambiental una de las causas de su presentación. La contaminación del aire causa morbilidad y mortalidad significativas en pacientes con enfermedades inflamatorias de las vías respiratorias como rinitis alérgica, rinosinusitis crónica, asma y enfermedad pulmonar obstructiva crónica. El estrés oxidativo en pacientes con enfermedades respiratorias puede inducir inflamación eosinofílica en las vías respiratorias, aumentar la sensibilización alérgica atópica y aumentar la susceptibilidad a infecciones. El cambio climático ha influido en la exposición a alérgenos extramuros y se asocia con exacerbaciones de enfermedades de la vía respiratoria superior e inferior. La interacción de las exposiciones ambientales en interiores y exteriores y los factores del huésped pueden afectar el desarrollo y la progresión de enfermedades alérgicas de por vida. La reducción de la exposición a los contaminantes del aire se ha asociado con una respuesta favorable en la salud respiratoria por lo cual es necesario implementar medidas que contribuyan a la mejoría en la calidad del aire.
{"title":"[Environmental pollution and allergy].","authors":"Sandra Nora González-Díaz, Cindy Elizabeth de Lira-Quezada, Rosalaura Virginia Villarreal-González, José Ignacio Canseco-Villarreal","doi":"10.29262/ram.v69iSupl1.1010","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.1010","url":null,"abstract":"La contaminación del aire, el cambio climático y la reducción de la diversidad biológica son amenazas importantes para la salud humana. En las últimas décadas se ha observado un aumento en las enfermedades alérgicas incluyendo asma y rinoconjuntivitis. Hasta al 40% de la población mundial pueden presentar alguna enfermedad alérgica representando un impacto significativo en la calidad de vida de quienes la padecen, siendo la contaminación ambiental una de las causas de su presentación. La contaminación del aire causa morbilidad y mortalidad significativas en pacientes con enfermedades inflamatorias de las vías respiratorias como rinitis alérgica, rinosinusitis crónica, asma y enfermedad pulmonar obstructiva crónica. El estrés oxidativo en pacientes con enfermedades respiratorias puede inducir inflamación eosinofílica en las vías respiratorias, aumentar la sensibilización alérgica atópica y aumentar la susceptibilidad a infecciones. El cambio climático ha influido en la exposición a alérgenos extramuros y se asocia con exacerbaciones de enfermedades de la vía respiratoria superior e inferior. La interacción de las exposiciones ambientales en interiores y exteriores y los factores del huésped pueden afectar el desarrollo y la progresión de enfermedades alérgicas de por vida. La reducción de la exposición a los contaminantes del aire se ha asociado con una respuesta favorable en la salud respiratoria por lo cual es necesario implementar medidas que contribuyan a la mejoría en la calidad del aire.","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s24-s30"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39798203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.29262/ram.v69iSupl1.1018
Patricia María O Farrill-Romanillos, José Efraín Bermúdez-Márquez, Edwin Daniel Maldonado-Domínguez, Nancy Valeria López-Moreno, Juan José Reyes-Aguilar, Karen Lilian Rivera-Alvarado, Silvia Paulina Ruiz-López, Diana Andrea Herrera-Sánchez
Pollen-food syndrome (PFS) is characterized by allergic sensitization to proteins of pollens of grasses, weeds, and trees, which produce a type I hypersensitivity reaction that is associated with the intake of plant-derived foods that are usually in raw form. The most frequently-associated protein families are: profilins, PR-10, and ns LTP; however, others such as thaumatins, isoflavones, reductases, and B1,2 glucanases have been documented. The prototype syndrome is birch-fruit-vegetables, and of these, the most common is birch-apple due to the fact that more than 70 % of patients who are sensitized to birch present symptoms associated with the intake of plant-derived foods. The symptoms are restricted to the oral cavity; however, some patients may present systemic symptoms, including anaphylaxis, so it is important to identify the type of protein that is involved since the type of reaction that the patient may present depends on that. In spite of everything, it is considered an entity that may be under diagnosed due to its complex diagnosis and treatment, since the procedure, in most cases, is an elimination diet, because treatment with immunotherapy is not yet available. The purpose of this review is to describe the pathophysiology, as well as the most common pollen-food syndromes.
{"title":"[Pollen-food syndrom. A rewiev with a twist].","authors":"Patricia María O Farrill-Romanillos, José Efraín Bermúdez-Márquez, Edwin Daniel Maldonado-Domínguez, Nancy Valeria López-Moreno, Juan José Reyes-Aguilar, Karen Lilian Rivera-Alvarado, Silvia Paulina Ruiz-López, Diana Andrea Herrera-Sánchez","doi":"10.29262/ram.v69iSupl1.1018","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.1018","url":null,"abstract":"<p><p>Pollen-food syndrome (PFS) is characterized by allergic sensitization to proteins of pollens of grasses, weeds, and trees, which produce a type I hypersensitivity reaction that is associated with the intake of plant-derived foods that are usually in raw form. The most frequently-associated protein families are: profilins, PR-10, and ns LTP; however, others such as thaumatins, isoflavones, reductases, and B1,2 glucanases have been documented. The prototype syndrome is birch-fruit-vegetables, and of these, the most common is birch-apple due to the fact that more than 70 % of patients who are sensitized to birch present symptoms associated with the intake of plant-derived foods. The symptoms are restricted to the oral cavity; however, some patients may present systemic symptoms, including anaphylaxis, so it is important to identify the type of protein that is involved since the type of reaction that the patient may present depends on that. In spite of everything, it is considered an entity that may be under diagnosed due to its complex diagnosis and treatment, since the procedure, in most cases, is an elimination diet, because treatment with immunotherapy is not yet available. The purpose of this review is to describe the pathophysiology, as well as the most common pollen-food syndromes.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s38-s45"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39657050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.29262/ram.v69iSupl1.989
Pablo Perea-Valle, Carlos Julio Delgado-Aguirre, Belkis Grindeli Villafuerte-Domínguez, Blanca Estela Del Río-Navarro
Even though the SARS-CoV-2 pandemic represents a historical challenge, science has had an exponential development, and the current vaccination campaigns are proof of this. Unfortunately, along came misinformation and myths regarding their production and their adverse effects. For this reason, we have considered of utter importance to review anaphylaxis, one of the most feared vaccine adverse events.Anaphylaxis can be defined as a life-threatening acute and systemic allergic reaction, with a wide clinical spectrum, which can be explained by many immunological mechanisms, and whose diagnostic complexity demands the fulfillment of strict criteria. Though infrequent, any vaccine has the potential to trigger anaphylaxis. In the United States, for the new SARS-CoV-2 vaccines, rates from 1:200 000 (Pfizer-BioNTech) to 1:360 000 doses (Moderna) have been estimated. Vaccine adverse events can be mediated by hypersensitivity reactions, either allergic or not. Unlike a typical drug allergy, rarely is the active ingredient responsible for the reaction. Therefore, excipients must be considered during the approach to this problem. Vaccine associated anaphylaxis has to be referred to an allergist so as to guarantee the maximum benefit for the patient and improve the vaccines' security profile.
{"title":"[Anaphylaxis caused by vaccines].","authors":"Pablo Perea-Valle, Carlos Julio Delgado-Aguirre, Belkis Grindeli Villafuerte-Domínguez, Blanca Estela Del Río-Navarro","doi":"10.29262/ram.v69iSupl1.989","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.989","url":null,"abstract":"<p><p>Even though the SARS-CoV-2 pandemic represents a historical challenge, science has had an exponential development, and the current vaccination campaigns are proof of this. Unfortunately, along came misinformation and myths regarding their production and their adverse effects. For this reason, we have considered of utter importance to review anaphylaxis, one of the most feared vaccine adverse events.Anaphylaxis can be defined as a life-threatening acute and systemic allergic reaction, with a wide clinical spectrum, which can be explained by many immunological mechanisms, and whose diagnostic complexity demands the fulfillment of strict criteria. Though infrequent, any vaccine has the potential to trigger anaphylaxis. In the United States, for the new SARS-CoV-2 vaccines, rates from 1:200 000 (Pfizer-BioNTech) to 1:360 000 doses (Moderna) have been estimated. Vaccine adverse events can be mediated by hypersensitivity reactions, either allergic or not. Unlike a typical drug allergy, rarely is the active ingredient responsible for the reaction. Therefore, excipients must be considered during the approach to this problem. Vaccine associated anaphylaxis has to be referred to an allergist so as to guarantee the maximum benefit for the patient and improve the vaccines' security profile.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s1-s14"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39798201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.29262/ram.v69iSupl1.1046
Marco Venancio-Hernández, Elizabeth Mendieta-Flores, Jeannette Mendiola-Marín, Angélica Kathya Alaniz-Flores, Mireya Reyes-Arellano
Difficult-to-treat asthma refers to asthma that is not controlled despite high or medium doses of inhaled steroids or in which high doses of treatment are required to maintain an adequate control of the symptoms and to reduce the risk of exacerbations. An inadequate technique to use the inhaler, poor adherence to treatment, smoking, comorbidities, or an incorrect diagnosis should be considered. In severe asthma, despite adherence to treatment with optimized maximum doses and the management of factors that could contribute, multiple medications in maximum doses are required to have an adequate therapeutic control or this is not achieved. The approach to these patients involves a meticulous process due to the multiple factors that can influence poor asthma control and that can lead to a misclassification of the disease when, in reality, the patient can be presenting different comorbidities whose treatment could decrease the severity of asthma symptoms and modify the prognosis. The objective of this document is to make the approach to patients with difficult-to-treat asthma and severe asthma known, as well as the most frequent comorbidities. A search was made in PubMed with the purpose of identifying the main pathologies that may be present in patients and, based on what is described in the literature, to propose a diagnostic approach. 100 studies were comprised in this review, including clinical guidelines such as GINA, GEMA, and ERS/ATS.
{"title":"[The diagnostic approach to difficult-to-treat asthma and severe asthma].","authors":"Marco Venancio-Hernández, Elizabeth Mendieta-Flores, Jeannette Mendiola-Marín, Angélica Kathya Alaniz-Flores, Mireya Reyes-Arellano","doi":"10.29262/ram.v69iSupl1.1046","DOIUrl":"https://doi.org/10.29262/ram.v69iSupl1.1046","url":null,"abstract":"<p><p>Difficult-to-treat asthma refers to asthma that is not controlled despite high or medium doses of inhaled steroids or in which high doses of treatment are required to maintain an adequate control of the symptoms and to reduce the risk of exacerbations. An inadequate technique to use the inhaler, poor adherence to treatment, smoking, comorbidities, or an incorrect diagnosis should be considered. In severe asthma, despite adherence to treatment with optimized maximum doses and the management of factors that could contribute, multiple medications in maximum doses are required to have an adequate therapeutic control or this is not achieved. The approach to these patients involves a meticulous process due to the multiple factors that can influence poor asthma control and that can lead to a misclassification of the disease when, in reality, the patient can be presenting different comorbidities whose treatment could decrease the severity of asthma symptoms and modify the prognosis. The objective of this document is to make the approach to patients with difficult-to-treat asthma and severe asthma known, as well as the most frequent comorbidities. A search was made in PubMed with the purpose of identifying the main pathologies that may be present in patients and, based on what is described in the literature, to propose a diagnostic approach. 100 studies were comprised in this review, including clinical guidelines such as GINA, GEMA, and ERS/ATS.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s94-s111"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39657469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eliza Mireya Vázquez, Carlos Francisco Vázquez-Rodríguez, Nancy Virginia Ortega-Betancourt, Humberto Martínez-Montoya, Octelina Castillo-Ruiz, Francisco Vázquez-Nava
Objective: To determine the prevalence and risk factors associated with tobacco use during the period of confinement in light of the COVID-19 pandemic.
Methods: Through an analytical and cross-sectional study, the data of 2, 372 participants were analyzed. The information was collected through a self-administered questionnaire that was built with the Google Forms tool, which was distributed and applied via email and WhatsApp; the private messaging platform. The relationship between the independent variables and the outcome was determined by multivariate logistic regression analysis.
Results: Out of the total population, 69.3 % were women, the median age was 20.11±2.01 years, the prevalence of asthma was 12.2 %, and the active tobacco use was 13.3 %. There was a higher number of patients with asthma who smoked (14.2 vs. 13.2 %) than of those who didn't have asthma. The multivariate logistic regression analysis showed that factors like considering that COVID-19 does not exist and not being confined were related to tobacco use in patients with asthma during the implementation of the contingency plan that the COVID-19 pandemic represents.
Conclusions: During confinement to home for COVID-19, the prevalence of tobacco use is higher in patients with asthma than in individuals without this ailment; the factors that favor the aforementioned are present in the family environment.
{"title":"[Factors associated with tobacco use in patients with asthma during the confinement due to COVID-19 in an urban region with high numbers of SARS-CoV-2 infections].","authors":"Eliza Mireya Vázquez, Carlos Francisco Vázquez-Rodríguez, Nancy Virginia Ortega-Betancourt, Humberto Martínez-Montoya, Octelina Castillo-Ruiz, Francisco Vázquez-Nava","doi":"10.29262/ram.v68i4.922","DOIUrl":"https://doi.org/10.29262/ram.v68i4.922","url":null,"abstract":"<p><strong>Objective: </strong>To determine the prevalence and risk factors associated with tobacco use during the period of confinement in light of the COVID-19 pandemic.</p><p><strong>Methods: </strong>Through an analytical and cross-sectional study, the data of 2, 372 participants were analyzed. The information was collected through a self-administered questionnaire that was built with the Google Forms tool, which was distributed and applied via email and WhatsApp; the private messaging platform. The relationship between the independent variables and the outcome was determined by multivariate logistic regression analysis.</p><p><strong>Results: </strong>Out of the total population, 69.3 % were women, the median age was 20.11±2.01 years, the prevalence of asthma was 12.2 %, and the active tobacco use was 13.3 %. There was a higher number of patients with asthma who smoked (14.2 vs. 13.2 %) than of those who didn't have asthma. The multivariate logistic regression analysis showed that factors like considering that COVID-19 does not exist and not being confined were related to tobacco use in patients with asthma during the implementation of the contingency plan that the COVID-19 pandemic represents.</p><p><strong>Conclusions: </strong>During confinement to home for COVID-19, the prevalence of tobacco use is higher in patients with asthma than in individuals without this ailment; the factors that favor the aforementioned are present in the family environment.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"68 4","pages":"218-224"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39585752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
María José Rojas-Puell, Fernando M Runzer-Colmenares, Danna Salazar-Gastelú, Flor Santa Cruz-De Lama, Alejandra Medina-Hernández
Objective: To specify the association between atopic dermatitis and food allergies in students of Human Medicine in a private university in Lima-Peru.
Methods: An observational, analytical, cross-sectional study that included 355 students of human medicine between the ages of 18 and 25 years, of a private university in Lima-Peru, through a virtual survey. The data were analyzed using Fisher's technique, Student's T test, and Poisson regression.
Results: In a model that was adjusted by age and sex, having atopic dermatitis was associated with 5.53 times the probability of having food allergies (95 % confidence interval, 3.12-9.79).
Conclusions: There was an association between the precedent of atopic dermatitis and reported food allergies in 28.95 % of the students of human medicine of a private university in Lima-Peru.
{"title":"[Food allergy and its association with self-reported atopic dermatitis in young adults in Lima-Peru].","authors":"María José Rojas-Puell, Fernando M Runzer-Colmenares, Danna Salazar-Gastelú, Flor Santa Cruz-De Lama, Alejandra Medina-Hernández","doi":"10.29262/ram.v68i4.851","DOIUrl":"https://doi.org/10.29262/ram.v68i4.851","url":null,"abstract":"<p><strong>Objective: </strong>To specify the association between atopic dermatitis and food allergies in students of Human Medicine in a private university in Lima-Peru.</p><p><strong>Methods: </strong>An observational, analytical, cross-sectional study that included 355 students of human medicine between the ages of 18 and 25 years, of a private university in Lima-Peru, through a virtual survey. The data were analyzed using Fisher's technique, Student's T test, and Poisson regression.</p><p><strong>Results: </strong>In a model that was adjusted by age and sex, having atopic dermatitis was associated with 5.53 times the probability of having food allergies (95 % confidence interval, 3.12-9.79).</p><p><strong>Conclusions: </strong>There was an association between the precedent of atopic dermatitis and reported food allergies in 28.95 % of the students of human medicine of a private university in Lima-Peru.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"68 4","pages":"233-241"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39585755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}